Autolus Therapeutics (NASDAQ:AUTL – Get Rating) and Seagen (NASDAQ:SGEN – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, dividends, earnings, institutional ownership and profitability. Insider and Institutional Ownership 70.1% of Autolus Therapeutics shares are owned […]
Seagen (NASDAQ:SGEN – Get Rating) and Autolus Therapeutics (NASDAQ:AUTL – Get Rating) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends. Institutional & Insider Ownership 86.3% of Seagen shares are held by […]
Ellevest Inc. lifted its holdings in shares of Seagen Inc. (NASDAQ:SGEN – Get Rating) by 41.1% during the 1st quarter, HoldingsChannel.com reports. The firm owned 1,633 shares of the biotechnology company’s stock after buying an additional 476 shares during the period. Ellevest Inc.’s holdings in Seagen were worth $235,000 as of its most recent SEC […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Seagen (NASDAQ:SGEN – Get Rating) had its target price raised by SVB Leerink from $155.00 to $159.00 in a research report released on Monday morning, Stock Target Advisor reports. They currently have an outperform rating on the biotechnology company’s stock. Several other research firms have also issued reports on SGEN. Morgan Stanley increased their target […]